AAIC26: Alzheimer’s disease heterogeneity calls for a rethink
The Alzheimer’s space has surpassed several key milestones over the past few years, with the first disease-modifying therapies (DMTs) and…
13 Jul 2026
Podcast: Patient advocates join the blood cancer ASCT vs CAR-T debate
In recent years, there has been strong discourse in the blood cancer space around the best way to treat patients as the industry’s focus sharpens on keeping a patient’s cancer…
07 Jul 2026
Podcast: Servier describes its M&A and manufacturing strategy amidst deal-making drive
Following multibillion dollar asset acquisitions and artificial intelligence (AI)-centred deals, Servier’s head of business development outlines how one of France’s leading pharma companies is planning for the future amidst a…
04 Jul 2026
Between two giants: Europe’s new oncology chapter takes shape in Paris
The opening of THE HIVE at Campus Grand Parc was marked not simply by the inauguration of a new laboratory building, but by a broader statement of intent about Europe’s…
03 Jul 2026
The celebrity prescription: star power meets healthcare
For years, Serena Williams was the defining face of women’s tennis. Now, her ongoing alliance with a telehealth company may be signifying a broader shift in US healthcare advertising, reflecting…
02 Jul 2026
Podcast: HLTH Europe and BIO key trends rundown
June was a busy month for Pharmaceutical Technology’s editorial team, with journalists attending several key conferences with reach across the healthcare and life science sectors. This includes the BIO International…
01 Jul 2026
Beyond the GLP-1RA weight loss ceiling
On 21 May 21, 2026, Eli Lilly’s retatrutide achieved a historic first; as of June 2026, it is the only drug to produce an average weight loss above 30% in…